About Lawrence T. Wang

Lawrence spent time working in Uganda the summer after his first year of medical school, where he learned of the ongoing prevalence of malaria despite the availability of antimalarial drugs. This experience led Lawrence to pause medical school and apply to graduate school so that he could research vaccines for preventing malaria. Lawrence went on to earn a Doctor of Philosophy (DPhil) in biomedical sciences from the University of Oxford and the NIH for his research on antimalarial monoclonal antibodies in the labs of Simon Draper and Robert Seder, respectively. The highlight of Lawrence’s graduate school experience was his discovery of a monoclonal antibody that potently prevents malaria, which completed Phase I testing at the NIH and was shown to protect children from malaria in a Phase II trial in Mali. This antibody is being investigated in several ongoing clinical trials in Africa. After obtaining his DPhil, Lawrence returned to UCSD to complete his Doctor of Medicine (MD) supported by the PD Soros Fellowship.

Lawrence subsequently completed an accelerated internal medicine residency and is currently an infectious diseases fellow in Weill Cornell’s Medical Research Track.